Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Lance Wilkes"


4 mentions found


REUTERS/Andrew Kelly/File Photo Acquire Licensing RightsNov 29 (Reuters) - Cigna (CI.N) and Humana (HUM.N), two of the biggest U.S. health insurers, are in talks for what could be the largest merger announced in 2023, according to a source familiar with the matter. A Humana and Cigna combination would give the merged company the scale to rival UnitedHealth Group (UNH.N) and CVS Health (CVS.N). In July 2016, the Justice Department filed lawsuits against two health insurance mergers on the same day, saying they would lead to less competition and higher prices for Americans. Health insurers have been facing higher medical costs as people return for procedures they had put off during the pandemic. Humana in February said that it would sell its commercial business but keep its Medicare Advantage products.
Persons: Andrew Kelly, Cigna, Cigna's, Aetna, Bill Baer, Andre Barlow of Doyle, Barlow, Mazard, Bernstein, Lance Wilkes, Craig Garthwaite, Manas Mishra, Diane Bartz, Deena Beasley, Caroline Humer, Bill Berkrot Organizations: Humana Inc, REUTERS, Street Journal, UnitedHealth, CVS Health, Humana’s, Medicare, Affordable, Justice Department, Humana, U.S ., Reuters, Northwestern University, Thomson Locations: Queens , New York City, U.S, Cigna, Bengaluru, Washington, Los Angeles
As the economy slows down, investors will want to play defense with dividend strategies, according to Wolfe Research. "In a later cycle environment, dividend growth becomes scarce and investors tend to pay up for companies with high dividend growth," analyst Chris Senyek wrote in a note last week. Therefore, the strategy is to look for names with both high dividend growth and a high free cash flow yield, since investors look to cash flow to support further dividend growth, he said. Comcast has an average analyst rating of overweight and has nearly 10% upside to the average price target, according to FactSet. Lennar is also well-liked by analysts, with an average rating of overweight and about 20% upside to the average price target, per FactSet.
Persons: Chris Senyek, Senyek, Peacock, Morgan Stanley, Benjamin Swinburne, Lennar, Raymond James, Buck Horne, UnitedHealth, Bernstein, Lance Wilkes, — CNBC's Michael Bloom Organizations: Wolfe Research, Comcast, Media, CNBC
UnitedHealth is worth buying as it still trades at a cheap valuation coming out of a good earnings report, according to Bernstein. Analyst Lance Wilkes upgraded the health insurance stock to outperform from market perform and raised his price target by $8 to $603. Now, he said those concerns are priced into the stock and valuation has fallen (from around 1.3 times earnings to 0.9 times earnings) to a level that undervalues the long-term growth opportunity. Despite the post-earnings rally, the Dow Jones Industrial Average member is still down nearly 9% in 2023 despite the broader market's rise. UnitedHealth trades at a 0.9 multiple relative to the S & P 500, near the Medicare-for-All lows of 0.85.
Persons: Bernstein, Lance Wilkes, Wilkes, UnitedHealth, That's, , Michael Bloom Organizations: Dow Jones Industrial Locations: Monday's
UnitedHealth Group has the highest price per share of any company on the Dow Jones Industrial Average and it's the tenth heaviest-weighted stock on the S&P 500. In fact, not only is UnitedHealth the biggest health-care conglomerate in the United States based on market cap and revenue, it's even bigger than JPMorgan Chase, the nation's largest bank. "If I had to pick one stock, only one stock to buy, I'd buy United[Health]," said Ana Gupte, principal at AG Health Advisors. "UnitedHealth Group is committed to improving the health system for everyone, advancing evidence-based practice and aligning incentives across the system to ensure people get the right care at the right time in the right place," UnitedHealth Group told CNBC. Watch the video above to learn how UnitedHealth Group grew so big and what that means for the U.S. health-care system.
Total: 4